NeuroPace Medical (NPCE): Enterprise Value to EBITDA Ratio
This EV/EBITDA price chart illustrating valuation trends for NeuroPace, Inc. (NPCE) shows a metric of 0.00. NeuroPace, Inc. (NPCE) specializes in suppressing epileptic seizures using intelligent RNS systems. The company has outsourced electronics production to external CMOS contractors while keeping key development in-house. To avoid single-product dependency, the business is expanding its service maintenance and components sales segment.
Comprehensive metric breakdowns and analytics for neuropace.com (NPCE)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
- financial results and valuation multiples details:
NPCE - Net Financial Result|Projected Future Earnings NeuroPace, Inc.|NPCE - Price to Earnings Ratio|Forward P/E Multiple NeuroPace, Inc.|NPCE - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroPace Medical|NPCE - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months NeuroPace|NPCE - Earnings per share for the trailing year|Quarterly EPS earnings growth neuropace.com|NPCE - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year NeuroPace, Inc.
Analysis of all company metrics:NeuroPace Corp NPCE
Investors determine an asset's margin of safety through the ratio of total enterprise value to EBITDA. The experienced management of NeuroPace, Inc. (NPCE) is effectively scaling the deployment of neurostimulators while minimizing the risks of inefficient capital management. When analyzing the NeuroPace, Inc. (NPCE) EV/EBITDA multiple chart, one must consider the impact of the debt burden on the overall market valuation. Exceeding critical thresholds transforms the asset into an overheated instrument with a high risk of a drawdown.
Competitor analysis
Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (CONMED Corp.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Medical (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode Ltd.)|PMI (picardmedical.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics SRDX|SENS - Enterprise Value to EBITDA Ratio|Tactile Systems Technology Inc. - EV/EBITDA Multiple|Company Value to EBITDA SANUWAVE Health Inc|OM: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation ELMD|LNSR (LENSAR) - EV/EBITDA Multiple|AVITA Medical Inc. (RCEL) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple PROF|Enterprise Value to EBITDA Ratio bairdmed.com BDMD|EV/EBITDA Multiple EDAP (EDAP TMS)|EV/EBITDA Multiple Apyx Medical Corp APYX|ICCM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TELA (telabio.com) - Enterprise Value to EBITDA Ratio|CytoSorbents Corporation - Business Value to Operating Income Before Depreciation|SRTS (Sensus Healthcare, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA zynex.com ZYXI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization electroCore, Inc. (ECOR)|vicarioussurgical.com (RBOT) - Enterprise Value to EBITDA Multiple|Inspira Technologies - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple SeaStar Medical Holding Corp. ICU|IRIDEX Corp. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Intelligent Bio Solutions INBS|beyondair.net (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa Inc.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STRATA Skin Sciences Inc.|Enterprise Value to EBITDA Ratio GlucoTrack Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BioSig Technologies, Inc. (BSGM) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation CUTR|KNW (Know Labs) - EV/EBITDA Multiple|Company Value to EBITDA Inari Medical Inc NARI|Enterprise Value to EBITDA Ratio NVRO (Nevro Corporation)|EV/EBITDA Multiple reshapelifesciences.com (RSLS)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Silk Road Medical, Inc SILK
